{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T20:59:45Z","timestamp":1793134785408,"version":"4.5.0"},"reference-count":48,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2019,4,9]],"date-time":"2019-04-09T00:00:00Z","timestamp":1554768000000},"content-version":"am","delay-in-days":1,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1093\/cvr\/cvz097","type":"journal-article","created":{"date-parts":[[2019,4,4]],"date-time":"2019-04-04T19:24:03Z","timestamp":1554405843000},"source":"Crossref","is-referenced-by-count":18,"title":["Reversion of cardiac dysfunction by a novel orally available calcium\/calmodulin-dependent protein kinase II inhibitor, RA306, in a genetic model of dilated cardiomyopathy"],"prefix":"10.1093","author":[{"given":"Philippe","family":"Beauverger","sequence":"first","affiliation":[{"name":"Cardiovascular&Metabolism Therapeutic Area, Sanofi R&D, 1 avenue Pierre Brossolette, Chilly-Mazarin, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Laure","family":"Ozoux","sequence":"additional","affiliation":[{"name":"Cardiovascular&Metabolism Therapeutic Area, Sanofi R&D, 1 avenue Pierre Brossolette, Chilly-Mazarin, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"B\u00e9gis","sequence":"additional","affiliation":[{"name":"Integrated Drug Discovery platform, Sanofi R&D, 1 avenue Pierre Brossolette, Chilly-Mazarin, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Gl\u00e9nat","sequence":"additional","affiliation":[{"name":"Integrated Drug Discovery platform, Sanofi R&D, 13 quai Jules Guesde, Vitry-sur-Seine Cedex, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Briand","sequence":"additional","affiliation":[{"name":"Cardiovascular&Metabolism Therapeutic Area, Sanofi R&D, 1 avenue Pierre Brossolette, Chilly-Mazarin, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Claire","family":"Philippo","sequence":"additional","affiliation":[{"name":"Cardiovascular&Metabolism Therapeutic Area, Sanofi R&D, 1 avenue Pierre Brossolette, Chilly-Mazarin, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyril","family":"Daveu","sequence":"additional","affiliation":[{"name":"Cardiovascular&Metabolism Therapeutic Area, Sanofi R&D, 1 avenue Pierre Brossolette, Chilly-Mazarin, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georges","family":"Tavares","sequence":"additional","affiliation":[{"name":"Cardiovascular&Metabolism Therapeutic Area, Sanofi R&D, 1 avenue Pierre Brossolette, Chilly-Mazarin, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Roy","sequence":"additional","affiliation":[{"name":"Integrated Drug Discovery platform, Sanofi R&D, 13 quai Jules Guesde, Vitry-sur-Seine Cedex, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Corbier","sequence":"additional","affiliation":[{"name":"Cardiovascular&Metabolism Therapeutic Area, Sanofi R&D, 1 avenue Pierre Brossolette, Chilly-Mazarin, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascale","family":"Briand","sequence":"additional","affiliation":[{"name":"Cardiovascular&Metabolism Therapeutic Area, Sanofi R&D, 1 avenue Pierre Brossolette, Chilly-Mazarin, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Dorchies","sequence":"additional","affiliation":[{"name":"Preclinical Safety platform, Sanofi R&D, 13 quai Jules Guesde, Vitry-sur-Seine Cedex, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Laure","family":"Bauchet","sequence":"additional","affiliation":[{"name":"Translational Medicine and Early Development platform, Sanofi R&D, 13 quai Jules Guesde, Vitry-sur-Seine Cedex, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Nicolai","sequence":"additional","affiliation":[{"name":"Integrated Drug Discovery platform, Sanofi R&D, 1 avenue Pierre Brossolette, Chilly-Mazarin, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Duclos","sequence":"additional","affiliation":[{"name":"Integrated Drug Discovery platform, Sanofi R&D, 1 avenue Pierre Brossolette, Chilly-Mazarin, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doroth\u00e9e","family":"Tamarelle","sequence":"additional","affiliation":[{"name":"Biostatistics and Programming platform, Sanofi R&D, 13 quai Jules Guesde, Vitry-sur-Seine Cedex, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Pierre","family":"Pruniaux","sequence":"additional","affiliation":[{"name":"Cardiovascular&Metabolism Therapeutic Area, Sanofi R&D, 1 avenue Pierre Brossolette, Chilly-Mazarin, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony J","family":"Muslin","sequence":"additional","affiliation":[{"name":"Cardiovascular&Metabolism Therapeutic Area, Sanofi R&D, 640 Memorial Drive, MA, Cambridge, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7902-2514","authenticated-orcid":false,"given":"Philip","family":"Janiak","sequence":"additional","affiliation":[{"name":"Cardiovascular&Metabolism Therapeutic Area, Sanofi R&D, 1 avenue Pierre Brossolette, Chilly-Mazarin, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,4,8]]},"reference":[{"key":"2019043007432413600_cvz097-B1","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1016\/j.jacc.2013.05.019","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"62","author":"Yancy","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2019043007432413600_cvz097-B2","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1161\/CIRCULATIONAHA.109.192064","article-title":"2009 focused update: ACCF\/AHA guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation","volume":"119","author":"Jessup","year":"2009","journal-title":"Circulation"},{"key":"2019043007432413600_cvz097-B3","first-page":"e154","article-title":"guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society","volume":"112","author":"Hunt","year":"2005","journal-title":"Circulation"},{"key":"2019043007432413600_cvz097-B4","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1042\/bj20020228","article-title":"Structure-function of the multifunctional Ca2+\/calmodulin-dependent protein kinase II","volume":"364","author":"Hudmon","year":"2002","journal-title":"Biochem J"},{"key":"2019043007432413600_cvz097-B5","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1126\/science.1321493","article-title":"Impaired spatial learning in alpha-calcium-calmodulin kinase II mutant mice","volume":"257","author":"Silva","year":"1992","journal-title":"Science"},{"key":"2019043007432413600_cvz097-B6","doi-asserted-by":"crossref","first-page":"e105191.","DOI":"10.1371\/journal.pone.0105191","article-title":"Generation and behavior characterization of CaMKIIbeta knockout mice","volume":"9","author":"Bachstetter","year":"2014","journal-title":"PLoS One"},{"key":"2019043007432413600_cvz097-B7","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.yjmcc.2011.01.012","article-title":"CaMKII in myocardial hypertrophy and heart failure","volume":"51","author":"Anderson","year":"2011","journal-title":"J Mol Cell Cardiol"},{"key":"2019043007432413600_cvz097-B8","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1161\/CIRCRESAHA.111.243956","article-title":"Calmodulin-dependent protein kinase II: linking heart failure and arrhythmias","volume":"110","author":"Swaminathan","year":"2012","journal-title":"Circ Res"},{"key":"2019043007432413600_cvz097-B9","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1161\/01.RES.84.6.713","article-title":"Identification and expression of delta-isoforms of the multifunctional Ca2+\/calmodulin-dependent protein kinase in failing and nonfailing human myocardium","volume":"84","author":"Hoch","year":"1999","journal-title":"Circ Res"},{"key":"2019043007432413600_cvz097-B10","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/S0008-6363(98)00296-X","article-title":"Activity of cAMP-dependent protein kinase and Ca2+\/calmodulin-dependent protein kinase in failing and nonfailing human hearts","volume":"42","author":"Kirchhefer","year":"1999","journal-title":"Cardiovasc Res"},{"key":"2019043007432413600_cvz097-B11","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1161\/CIRCRESAHA.110.220418","article-title":"Inhibition of elevated Ca2+\/calmodulin-dependent protein kinase II improves contractility in human failing myocardium","volume":"107","author":"Sossalla","year":"2010","journal-title":"Circ Res"},{"key":"2019043007432413600_cvz097-B12","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1161\/CIRCULATIONAHA.113.001746","article-title":"Ca2+\/calmodulin-dependent protein kinase II and protein kinase A differentially regulate sarcoplasmic reticulum Ca2+ leak in human cardiac pathology","volume":"128","author":"Fischer","year":"2013","journal-title":"Circulation"},{"key":"2019043007432413600_cvz097-B13","first-page":"1940","article-title":"Calmodulin kinase II-mediated sarcoplasmic reticulum Ca2+ leak promotes atrial fibrillation in mice","volume":"119","author":"Chelu","year":"2009","journal-title":"J Clin Invest"},{"key":"2019043007432413600_cvz097-B14","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1161\/CIRCULATIONAHA.111.067306","article-title":"Enhanced sarcoplasmic reticulum Ca2+ leak and increased Na+-Ca2+ exchanger function underlie delayed afterdepolarizations in patients with chronic atrial fibrillation","volume":"125","author":"Voigt","year":"2012","journal-title":"Circulation"},{"key":"2019043007432413600_cvz097-B15","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1161\/CIRCULATIONAHA.112.134932","article-title":"Late sodium current inhibition reverses electromechanical dysfunction in human hypertrophic cardiomyopathy","volume":"127","author":"Coppini","year":"2013","journal-title":"Circulation"},{"key":"2019043007432413600_cvz097-B16","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/nature12537","article-title":"Diabetic hyperglycaemia activates CaMKII and arrhythmias by O-linked glycosylation","volume":"502","author":"Erickson","year":"2013","journal-title":"Nature"},{"key":"2019043007432413600_cvz097-B17","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1074\/jbc.M108525200","article-title":"The cardiac-specific nuclear delta(B) isoform of Ca2+\/calmodulin-dependent protein kinase II induces hypertrophy and dilated cardiomyopathy associated with increased protein phosphatase 2A activity","volume":"277","author":"Zhang","year":"2002","journal-title":"J Biol Chem"},{"key":"2019043007432413600_cvz097-B18","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1161\/01.RES.0000069686.31472.C5","article-title":"The deltaC isoform of CaMKII is activated in cardiac hypertrophy and induces dilated cardiomyopathy and heart failure","volume":"92","author":"Zhang","year":"2003","journal-title":"Circ Res"},{"key":"2019043007432413600_cvz097-B19","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1172\/JCI26620","article-title":"Ca2+\/calmodulin-dependent protein kinase II regulates cardiac Na+ channels","volume":"116","author":"Wagner","year":"2006","journal-title":"J Clin Invest"},{"key":"2019043007432413600_cvz097-B20","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/nm1215","article-title":"Calmodulin kinase II inhibition protects against structural heart disease","volume":"11","author":"Zhang","year":"2005","journal-title":"Nat Med"},{"key":"2019043007432413600_cvz097-B21","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1073\/pnas.0813013106","article-title":"The delta isoform of CaM kinase II is required for pathological cardiac hypertrophy and remodeling after pressure overload","volume":"106","author":"Backs","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019043007432413600_cvz097-B22","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1172\/JCI38022","article-title":"Requirement for Ca2+\/calmodulin-dependent kinase II in the transition from pressure overload-induced cardiac hypertrophy to heart failure in mice","volume":"119","author":"Ling","year":"2009","journal-title":"J Clin Invest"},{"key":"2019043007432413600_cvz097-B23","doi-asserted-by":"crossref","first-page":"65.","DOI":"10.1007\/s00395-016-0581-2","article-title":"Inducible cardiomyocyte-specific deletion of CaM kinase II protects from pressure overload-induced heart failure","volume":"111","author":"Kreusser","year":"2016","journal-title":"Basic Res Cardiol"},{"key":"2019043007432413600_cvz097-B24","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1161\/CIRCULATIONAHA.109.935296","article-title":"Ca2+\/calmodulin-dependent kinase IIdelta causes heart failure by accumulation of p53 in dilated cardiomyopathy","volume":"122","author":"Toko","year":"2010","journal-title":"Circulation"},{"key":"2019043007432413600_cvz097-B25","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1161\/CIRCULATIONAHA.106.644583","article-title":"Death, cardiac dysfunction, and arrhythmias are increased by calmodulin kinase II in calcineurin cardiomyopathy","volume":"114","author":"Khoo","year":"2006","journal-title":"Circulation"},{"key":"2019043007432413600_cvz097-B26","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1161\/01.CIR.0000027583.73268.E7","article-title":"Calmodulin kinase II and arrhythmias in a mouse model of cardiac hypertrophy","volume":"106","author":"Wu","year":"2002","journal-title":"Circulation"},{"key":"2019043007432413600_cvz097-B27","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1161\/CIRCHEARTFAILURE.109.865279","article-title":"Calcium\/calmodulin-dependent protein kinase II contributes to cardiac arrhythmogenesis in heart failure","volume":"2","author":"Sag","year":"2009","journal-title":"Circ Heart Fail"},{"key":"2019043007432413600_cvz097-B28","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1161\/CIRCULATIONAHA.114.006185","article-title":"Cardiac CaM Kinase II genes delta and gamma contribute to adverse remodeling but redundantly inhibit calcineurin-induced myocardial hypertrophy","volume":"130","author":"Kreusser","year":"2014","journal-title":"Circulation"},{"key":"2019043007432413600_cvz097-B29","author":"Beauverger","year":"2012"},{"key":"2019043007432413600_cvz097-B30","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1038\/nbt.1990","article-title":"Comprehensive analysis of kinase inhibitor selectivity","volume":"29","author":"Davis","year":"2011","journal-title":"Nat Biotechnol"},{"key":"2019043007432413600_cvz097-B31","doi-asserted-by":"crossref","first-page":"13333","DOI":"10.1016\/S0021-9258(18)69309-3","article-title":"Sequence analysis of phospholamban. Identification of phosphorylation sites and two major structural domains","volume":"261","author":"Simmerman","year":"1986","journal-title":"J Biol Chem"},{"key":"2019043007432413600_cvz097-B32","doi-asserted-by":"crossref","first-page":"12950","DOI":"10.1016\/S0021-9258(18)51579-9","article-title":"Expression and site-specific mutagenesis of phospholamban. Studies of residues involved in phosphorylation and pentamer formation","volume":"264","author":"Fujii","year":"1989","journal-title":"J Biol Chem"},{"key":"2019043007432413600_cvz097-B33","doi-asserted-by":"crossref","first-page":"11468","DOI":"10.1016\/S0021-9258(18)60487-9","article-title":"Phospholamban phosphorylation in intact ventricles. Phosphorylation of serine 16 and threonine 17 in response to beta-adrenergic stimulation","volume":"264","author":"Wegener","year":"1989","journal-title":"J Biol Chem"},{"key":"2019043007432413600_cvz097-B34","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.cell.2008.02.048","article-title":"A dynamic pathway for calcium-independent activation of CaMKII by methionine oxidation","volume":"133","author":"Erickson","year":"2008","journal-title":"Cell"},{"key":"2019043007432413600_cvz097-B35","doi-asserted-by":"crossref","first-page":"H1697","DOI":"10.1152\/ajpheart.00595.2009","article-title":"Regulation of VASP phosphorylation in cardiac myocytes: differential regulation by cyclic nucleotides and modulation of protein expression in diabetic and hypertrophic heart","volume":"297","author":"Sartoretto","year":"2009","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2019043007432413600_cvz097-B36","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1126\/science.280.5364.750","article-title":"Actin mutations in dilated cardiomyopathy, a heritable form of heart failure","volume":"280","author":"Olson","year":"1998","journal-title":"Science"},{"key":"2019043007432413600_cvz097-B37","doi-asserted-by":"crossref","first-page":"21.","DOI":"10.3389\/fphar.2014.00021","article-title":"CaMKII inhibitors: from research tools to therapeutic agents","volume":"5","author":"Pellicena","year":"2014","journal-title":"Front Pharmacol"},{"key":"2019043007432413600_cvz097-B38","doi-asserted-by":"crossref","first-page":"H57","DOI":"10.1152\/ajpheart.00512.2011","article-title":"Increases in intracellular sodium activate transcription and gene expression via the salt-inducible kinase 1 network in an atrial myocyte cell line","volume":"303","author":"Popov","year":"2012","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2019043007432413600_cvz097-B39","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/j.1476-5381.2009.00567.x","article-title":"The mixed-lineage kinase 1-3 signalling pathway regulates stress response in cardiac myocytes via GATA-4 and AP-1 transcription factors","volume":"159","author":"Ola","year":"2010","journal-title":"Br J Pharmacol"},{"key":"2019043007432413600_cvz097-B40","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.yjmcc.2014.03.021","article-title":"Cardiomyocyte-specific expression of CRNK, the C-terminal domain of PYK2, maintains ventricular function and slows ventricular remodeling in a mouse model of dilated cardiomyopathy","volume":"72","author":"Koshman","year":"2014","journal-title":"J Mol Cell Cardiol"},{"key":"2019043007432413600_cvz097-B41","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.15252\/emmm.201403848","article-title":"CaM Kinase II mediates maladaptive post-infarct remodeling and pro-inflammatory chemoattractant signaling but not acute myocardial ischemia\/reperfusion injury","volume":"6","author":"Weinreuter","year":"2014","journal-title":"EMBO Mol Med"},{"key":"2019043007432413600_cvz097-B42","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1006\/jmcc.2002.2037","article-title":"Calcium cycling in congestive heart failure","volume":"34","author":"Hasenfuss","year":"2002","journal-title":"J Mol Cell Cardiol"},{"key":"2019043007432413600_cvz097-B43","doi-asserted-by":"crossref","first-page":"360.","DOI":"10.1007\/s00395-013-0360-2","article-title":"Novel aspects of excitation-contraction coupling in heart failure","volume":"108","author":"Neef","year":"2013","journal-title":"Basic Res Cardiol"},{"key":"2019043007432413600_cvz097-B44","first-page":"547.","article-title":"3310\u2014RA123456, a novel potent and selective CaMKII inhibitor reduces diastolic Ca2+ leak and enhances SR Ca2+ content in human cardiomyocytes","volume":"36","author":"Dryzmalski","year":"2015","journal-title":"Eur Heart J"},{"key":"2019043007432413600_cvz097-B45","first-page":"620","article-title":"P3123\u2014the CaMKII inhibitor RA123456 attenuates heart failure and prevents ventricular and atrial arrhythmias in vivo","volume":"37","author":"Mustroph","year":"2016","journal-title":"Eur Heart J"},{"key":"2019043007432413600_cvz097-B46","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.yjmcc.2017.12.015","article-title":"Improvement of cardiomyocyte function by a novel pyrimidine-based CaMKII-inhibitor","volume":"115","author":"Neef","year":"2018","journal-title":"J Mol Cell Cardiol"},{"key":"2019043007432413600_cvz097-B47","doi-asserted-by":"crossref","first-page":"45.","DOI":"10.1007\/s00395-017-0637-y","article-title":"Reduction of SR Ca(2+) leak and arrhythmogenic cellular correlates by SMP-114, a novel CaMKII inhibitor with oral bioavailability","volume":"112","author":"Neef","year":"2017","journal-title":"Basic Res Cardiol"},{"key":"2019043007432413600_cvz097-B48","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.yjmcc.2018.03.020","article-title":"The novel CaMKII inhibitor GS-680 reduces diastolic SR Ca leak and prevents CaMKII-dependent pro-arrhythmic activity","volume":"118","author":"Lebek","year":"2018","journal-title":"J Mol Cell Cardiol"}],"container-title":["Cardiovascular Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cardiovascres\/advance-article-pdf\/doi\/10.1093\/cvr\/cvz097\/28544181\/cvz097.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/cardiovascres\/advance-article-pdf\/doi\/10.1093\/cvr\/cvz097\/28298368\/cvz097.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,15]],"date-time":"2022-09-15T08:03:03Z","timestamp":1663228983000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cardiovascres\/advance-article\/doi\/10.1093\/cvr\/cvz097\/5432645"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,8]]},"references-count":48,"URL":"https:\/\/doi.org\/10.1093\/cvr\/cvz097","relation":{},"ISSN":["0008-6363","1755-3245"],"issn-type":[{"value":"0008-6363","type":"print"},{"value":"1755-3245","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,8]]}}}